GlassScriptPhysician profile
Sapna Legha
NPI 1073899506
$5,230.70
in general payments reported to CMS, 2019-2025
41 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,118 · 2023: $1,824 · 2024: $1,579 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,563 · Travel and Lodging: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,563.48 |
| Travel and Lodging | $549.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,188.74 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Abiomed | $961.57 | 2023-2024 | Impella |
| Merck Sharp & Dohme LLC | $339.65 | 2022-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $307.34 | 2022-2025 | Bodyguardian, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $266.96 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $254.59 | 2022-2023 | Optimizer |
| Atricure, INC. | $172.22 | 2024-2025 | Synergy Ablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.18 | 2022-2025 | Lifevest |
| Paragonix Technologies, INC. | $160.04 | 2024 | |
| Baxter Healthcare | $152.70 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Coseal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.83 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $117.33 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $92.01 | 2022-2024 | Endurant Iis |
| Kestra Medical Technology Services, INC. | $72.62 | 2024 | Assure Wcd |
| Imperative Care, INC | $67.31 | 2024 | Prodigy Catheter |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $61.60 | 2025 | Endocross Device, Torus Stent Graft System |
| Heartflow, INC. | $59.09 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $57.12 | 2023-2024 | Wainua, Andexxa, Farxiga |
| Smith+Nephew, INC. | $56.34 | 2022-2025 | Renasys Touch, Stravix |
| Actelion Pharmaceuticals US, INC. | $56.22 | 2023-2024 | Opsumit, Uptravi |
| Daiichi Sankyo INC. | $52.27 | 2023-2024 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $36.86 | 2024 | Evkeeza |
| Novo Nordisk INC | $35.21 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $32.88 | 2025 | Livtencity |
| Cardiva Medical, INC. | $29.63 | 2024 | Savvywire |
| Elutia, INC. | $28.71 | 2022 | |
| Lsi Solutions INC | $28.71 | 2022 | |
| Edwards Lifesciences Corporation | $28.01 | 2024 | Mitris Resilia Mitral Valve |
| Cvrx, INC. | $24.32 | 2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $22.47 | 2022 | |
| Ge Healthcare | $19.83 | 2023 | |
| Polynovo North America LLC | $18.54 | 2023 | |
| Esperion Therapeutics, INC. | $18.48 | 2022 | |
| Biotissue Holdings INC. | $18.07 | 2024 | |
| Siemens Medical Solutions USA, INC. | $16.51 | 2022 | |
| Irhythm Technologies, INC. | $16.08 | 2024 | Zio Xt Patch, Zio Monitor |
| Lifenet Health | $15.24 | 2025 | Theragenesis Wound Matrix |
| Janssen Pharmaceuticals, INC | $15.14 | 2022 | |
| G Medical Diagnostic Services, INC. | $14.30 | 2022 | |
| Amgen INC. | $13.48 | 2024 | Repatha |
| Lemaitre Vascular, INC. | $11.50 | 2023 | Hydro Lemaitre Valvulotome |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sapna Legha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.